AUSTIN, Texas, Nov. 12 /PRNewswire/ -- SpineSmith Partners, an innovative bio-medical device company, is collaborating with several senior design teams in The University of Texas Biomedical Engineering Department to help educate students on the design, engineering, and commercialization process of medical devices.
Photo: http://www.ereleases.com/pr/2008-SpineSmith.jpg
The groups of biomedical engineering students will work closely with SpineSmith’s product engineers and Ph.D.s to take ideas conceptualized by practicing spine surgeons and design products for commercialization. This design process will educate the students and offer real world experience in the medical device industry.
SpineSmith is researching and developing the cutting edge market of regenerative medicine giving these students an opportunity to be involved with an evolving market. SpineSmith is currently researching and developing different technologies utilizing a patient’s own adult stem cells for tissue regeneration in orthopedics and the spine. With more than 10,000 stem cell cases to date, SpineSmith can revolutionize the regenerative medicine market and give these students an opportunity to make an impact in the product development process.
The mission of the Department of Biomedical Engineering at The University of Texas is to develop clinically translatable solutions for human health by training the next generation of biomedical engineers, cultivating leaders, and nurturing the integration of science, engineering, and medicine in a discover-centered environment.
“SpineSmith believes in the future of regenerative medicine and through this partnership we can utilize the distinguished students at The University of Texas to collaborate in the research and development of products that will impact patients throughout the world,” Steve Melchiode, president of SpineSmith, said.
SpineSmith believes collaborating with one of the nation’s largest research centers gives SpineSmith a competitive advantage to the numerous companies trying to enter the regenerative medicine market. The opportunity to work with the distinguished students of The University of Texas gives SpineSmith a wealth of knowledge and a source for job candidates who will be the future of the medical device marketplace.
About SpineSmith Partners, LP
(Logo: http://www.ereleases.com/pr/SpineSmith-logo.jpg )
SpineSmith Partners, LP designs, develops and markets implants and biologics for surgical fixation, correction and tissue regeneration of the spine. The company focuses on development of truly innovative biological and hardware technologies for use in the treatment of patients with spinal disorders. Fusionary(TM) is a product by SpineSmith, an Austin, Texas-based company. For more information, visit http://www.spinesmithusa.com or call 512.206.0770.
About UT, Austin
The University of Texas Department of Biomedical Engineering is a joint venture among The University of Texas at Austin, The University of Texas M.D. Anderson Cancer Center and the University of Texas Health Science Center at Houston. The multi-institutional effort combines the strength of one of the nation’s largest research universities, the nation’s top cancer research center, and a premier medical school.
This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.
CONTACT: Keri Kimler of SpineSmith, +1-512-206-0770; or Prof. James
Tunnell of UT, Austin, +1-512-232-2110
Web site: http://www.spinesmithusa.com/
